{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:46:50Z","timestamp":1793810810337,"version":"4.6.1"},"reference-count":51,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2024,9,13]]},"DOI":"10.1080\/14737167.2024.2365421","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T15:55:19Z","timestamp":1717862119000},"page":"953-966","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["A cost-effectiveness analysis of reduced viral transmission with baloxavir marboxil versus oseltamivir or no treatment for seasonal and pandemic influenza management in the United Kingdom"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3939-3940","authenticated-orcid":false,"given":"Svenn Alexander","family":"Kommandantvold","sequence":"first","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Lemenuel-Diot","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Skedgel","sequence":"additional","affiliation":[{"name":"Office of Health Economics, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pitman","sequence":"additional","affiliation":[{"name":"ICON plc, Reading, High Wycombe, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rouse","sequence":"additional","affiliation":[{"name":"Roche Products Ltd, Welwyn Garden City, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Zaraket","sequence":"additional","affiliation":[{"name":"Roche Products Ltd, Welwyn Garden City, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Blanchet Zumofen","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"e_1_3_8_3_1","unstructured":"Gov.UK [Internet]. Surveillance of influenza and other seasonal respiratory viruses in the UK Winter 2022 to 2023. London (UK): UK Health Security Agency; [cited 2023 Jul 3]. Available from https:\/\/www.gov.uk\/government\/statistics\/annual-flu-reports\/surveillance-of-influenza-and-other-seasonal-respiratory-viruses-in-the-uk-winter-2022-to-2023"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4571"},{"key":"e_1_3_8_5_1","unstructured":"The Health Foundation [Internet]. REAL Centre projections: general and acute hospital beds in England (2018-2030). London (UK); 2022 Jul [cited 2023 Jun 5]. Available from: https:\/\/www.health.org.uk\/sites\/default\/files\/upload\/publications\/2022\/Final_Beds_analysis_July2022.pdf"},{"key":"e_1_3_8_6_1","unstructured":"Nuffield Trust [Internet]. Hospital bed occupancy. London (UK); [cited 2023 Jun 27]. Available from: https:\/\/www.nuffieldtrust.org.uk\/resource\/hospital-bed-occupancy#hospital-bed-capacity-and-occupancy"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09553-0"},{"key":"e_1_3_8_8_1","unstructured":"Public Health England [Internet]. Surveillance of influenza and other respiratory viruses in the UK: Winter 2019 to 2020. London (UK); 2020 Jun [cited 2023 Aug 14]. Available from: http:\/\/allcatsrgrey.org.uk\/wp\/download\/public_health\/epidemiology\/Surveillance_Influenza_and_other_respiratory_viruses_in_the_UK_2019_to_2020_FINAL.pdf"},{"issue":"4","key":"e_1_3_8_9_1","article-title":"The societal and indirect economic burden of seasonal influenza in the United Kingdom","volume":"10","author":"Romanelli RJ","year":"2023","unstructured":"Romanelli RJ, Cabling M, Marciniak-Nuqui Z, et al. The societal and indirect economic burden of seasonal influenza in the United Kingdom. Rand Health Q. 2023;10(4).","journal-title":"Rand Health Q"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01224-9"},{"key":"e_1_3_8_11_1","unstructured":"National Institute for Health and Care Excellence [Internet]. Amantadine oseltamivir and zanamivir for the treatment of influenza. Technology appraisal guidance [TA168]. London (UK); [cited 2009 Feb 25]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta168"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30129-0"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051653"},{"key":"e_1_3_8_14_1","unstructured":"Gov.UK [Internet]. Health Security Agency. The flu vaccination: who should have it and why. London (UK): UK; [cited 2023 Sep 11]. Available from: https:\/\/www.gov.uk\/government\/publications\/flu-vaccination-who-should-have-it-this-winter-and-why\/the-flu-vaccination-who-should-have-it-and-why"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-016-0996-0"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12470"},{"issue":"1","key":"e_1_3_8_17_1","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza \u2014 recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore AE","year":"2011","unstructured":"Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza \u2014 recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(1):1\u201324.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70029-4"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm375"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1201.051370"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/600383"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1016"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/650458"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12046"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab625"},{"key":"e_1_3_8_26_1","unstructured":"Gov.UK [Internet]. Guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza. London (UK): UK Health Security Agency; 2021 Nov [cited 2023 Jun 12]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1058443\/ukhsa-guidance-antivirals-influenza-11v4.pdf"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70318-8"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/v7092850"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19151"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716197"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30004-9"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915341"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1415012112"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-480"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03063"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01241-6"},{"key":"e_1_3_8_37_1","volume-title":"Data on File (as supplied May 13, 2024).","author":"F. Hoffmann-La Roche Ltd","unstructured":"F. Hoffmann-La Roche Ltd. Data on File (as supplied May 13, 2024)."},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2018.1472805"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1821-7"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw841"},{"key":"e_1_3_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.05.012"},{"key":"e_1_3_8_42_1","unstructured":"National Institute for Health and Care Excellence [Internet]. Guide to the methods of technology appraisal 2013. London (UK); 2013 Apr 4 [cited 2023 Jul 11]. Available from: https:\/\/www.nice.org.uk\/process\/pmg9\/resources\/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781"},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198526629.001.0001"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13229"},{"key":"e_1_3_8_45_1","unstructured":"National Health Service England [Internet]. 2021\/22 National Cost Collection data publication. cited 2023 May 19]. Available from: https:\/\/www.england.nhs.uk\/publication\/2021-22-national-cost-collection-data-publication\/"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.7326\/0000605-200912150-00156"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01222-6"},{"key":"e_1_3_8_48_1","unstructured":"National Institute for Health and Care Excellence [Internet]. British National Formulary. London (UK); 2023 [cited 2023 Aug 1]. Available from: https:\/\/bnf.nice.org.uk\/drugs\/baloxavir-marboxil\/medicinal-forms\/"},{"key":"e_1_3_8_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16585-y"},{"key":"e_1_3_8_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010797"},{"key":"e_1_3_8_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-016-0178-8"},{"key":"e_1_3_8_52_1","unstructured":"Office of National Statistics [Internet]. Population estimates. 2021 [cited 2023 Jun 5]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates"},{"key":"e_1_3_8_53_1","unstructured":"National Health Service England [Internet]. Bed availability and occupancy data - overnight. 2022 [cited 2023 Aug 15]. Available from: https:\/\/www.england.nhs.uk\/statistics\/statistical-work-areas\/bed-availability-and-occupancy\/bed-data-overnight\/"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2024.2365421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T19:00:59Z","timestamp":1727204459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2024.2365421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,9,13]]}},"alternative-id":["10.1080\/14737167.2024.2365421"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2024.2365421","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}